NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Friedman BioVentures

Friedman BioVentures

San Diego, Californiabioventuresinvestors.com

Overview

Friedman BioVentures is a venture capital firm and family office investment arm that invests in early-stage biotechnology and pharmaceutical companies with a focus on platform technologies, oncology, neurodegenerative disease, and genomics.

Year Founded

2012

Portfolio Companies

2

Investments

Friedman BioVentures investments
CompanyDateStageLead
TRIO Pharmaceuticals, Inc.Mar 2023SeedLead
MedCryptJun 2018SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Diego, California
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.